KRT4 (Keratin, type II cytoskeletal 4) variants and mutations
KRT4 (also known as Keratin, type II cytoskeletal 4) is a human protein-coding gene encoding a keratin, type II cytoskeletal 4 protein. It contributes to intermediate filaments in non-keratinized mucosal epithelia, especially oral and esophageal surfaces. Dominant pathogenic variants can cause white sponge nevus, producing benign thickened white plaques of the mucosa. This analysis covers 968 KRT4 variants and mutations. Of these, 79% have computational variant effect predictions. Disease context includes white sponge nevus 1, White sponge nevus, and hereditary disease. Example KRT4 variants include M1?, I2T, and A3T.
Variant analysis overview
- Gene: KRT4
- Protein: Keratin, type II cytoskeletal 4
- UniProt accession: P19013
- Organism: Homo sapiens
- Variants analyzed: 968
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 720 unspecified-consequence records; 1 stop lost; 112 synonymous variants; 106 missense variants; 14 frameshift variants; 3 in-frame deletions; 9 stop-gained variants; 3 splice-region variants; 3 substitution
- Prediction scores: 760 variants have prediction scores (79% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: white sponge nevus 1, White sponge nevus, hereditary disease, esophageal squamous cell carcinoma, retinitis pigmentosa, Sjogren syndrome, hereditary gingival fibromatosis, mucous membrane pemphigoid, oculodental syndrome, Rutherfurd type, blistering, acantholytic, of oral and laryngeal mucosa, Fuchs endothelial corneal dystrophy, posterior polymorphous corneal dystrophy.
Protein structure and variant hotspots
- Protein features: 1 domains; 1 post-translational modification sites.
- Structural context: 591 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT4 variants
Examples include M1?, I2T, A3T, A3V, R4K, Q5*, Q5E, Q5R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV5340, Variant assessed as somatic; high impact.
- I2T (p.Ile2Thr), rs368182684, ClinGen CA6588871, ClinVar RCV002768529, ESP rs368182684, REVEL 0.05, CADD 22.90, Uncertain significance, Inborn genetic diseases
- A3T (p.Ala3Thr), gnomAD rs1315790135, REVEL 0.14, CADD 4.54
- A3V (p.Ala3Val), TOPMed rs867741067, gnomAD rs867741067, REVEL 0.15, CADD 22.60
- R4K (p.Arg4Lys), ExAC rs764236121, TOPMed rs764236121, REVEL 0.21, CADD 20.70
- Q5* (p.Gln5Ter), ExAC rs762899018, TOPMed rs762899018, gnomAD rs762899018, CADD 37.00
- Q5E (p.Gln5Glu), ExAC rs762899018, TOPMed rs762899018, gnomAD rs762899018, REVEL 0.20, CADD 23.90
- Q5R (p.Gln5Arg), ExAC rs776085274, TOPMed rs776085274, gnomAD rs776085274, REVEL 0.23, CADD 22.70
- Q6P (p.Gln6Pro), TOPMed rs1939965235, gnomAD rs1939965235, REVEL 0.15, CADD 18.30
- C7G (p.Cys7Gly), ExAC rs765638457, gnomAD rs765638457, REVEL 0.03, CADD 0.06, Likely benign, Inborn genetic diseases
- V8A (p.Val8Ala), ExAC rs760017217, TOPMed rs760017217, gnomAD rs760017217, REVEL 0.06, CADD 16.80
- V8D (p.Val8Asp), ExAC rs760017217, TOPMed rs760017217, gnomAD rs760017217, REVEL 0.48, CADD 22.50, Uncertain significance, Inborn genetic diseases
- R9* (p.Arg9Ter), rs886049646, NCI-TCGA Cosmic COSV5340, TOPMed rs886049646, gnomAD rs886049646, CADD 35.00, Uncertain significance
- R9G (p.Arg9Gly), rs886049646, ClinGen CA10642823, ClinVar RCV000282333, TOPMed rs886049646, REVEL 0.30, CADD 18.40, Uncertain significance, White sponge nevus 1
- R9P (p.Arg9Pro), rs950673957, NCI-TCGA Cosmic COSV5340, TOPMed rs950673957, gnomAD rs950673957, REVEL 0.51, CADD 23.10, Variant assessed as somatic; moderate impact.
- R9Q (p.Arg9Gln), TOPMed rs950673957, gnomAD rs950673957, REVEL 0.31, CADD 22.90
- G10C (p.Gly10Cys), ExAC rs777130445, gnomAD rs777130445, REVEL 0.34, CADD 21.70
- G10D (p.Gly10Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G10S (p.Gly10Ser), ExAC rs777130445, gnomAD rs777130445, REVEL 0.12, CADD 9.94
- G11R (p.Gly11Arg), rs371421345, ClinGen CA6588863, ClinVar RCV001110878, ClinVar RCV002558111, REVEL 0.36, CADD 19.20, Conflicting interpretations, White sponge nevus 1; Inborn genetic diseases
- P12L (p.Pro12Leu), gnomAD rs1381087134, REVEL 0.13, CADD 15.00
- R13P (p.Arg13Pro), ESP rs367746866, TOPMed rs367746866, gnomAD rs367746866, REVEL 0.30, CADD 14.00, Uncertain significance
- R13Q (p.Arg13Gln), rs367746866, ClinGen CA6588859, ClinVar RCV004412400, ESP rs367746866, REVEL 0.07, CADD 8.20, Uncertain significance, Inborn genetic diseases
- R13W (p.Arg13Trp), ExAC rs758581374, TOPMed rs758581374, gnomAD rs758581374, REVEL 0.42, CADD 23.90, Uncertain significance, Inborn genetic diseases
- S16N (p.Ser16Asn), TOPMed rs1020179413, REVEL 0.44, CADD 23.50
- C17S (p.Cys17Ser), Ensembl rs2121258326, REVEL 0.12, CADD 0.19
- G18S (p.Gly18Ser), gnomAD rs1939964030, REVEL 0.18, CADD 6.25
- S19L (p.Ser19Leu), rs761182348, NCI-TCGA Cosmic COSV9954, ExAC rs761182348, TOPMed rs761182348, REVEL 0.61, CADD 24.40, Variant assessed as somatic; moderate impact.
- A20D (p.Ala20Asp), ESP rs373604363, ExAC rs373604363, TOPMed rs373604363, gnomAD rs373604363, REVEL 0.34, CADD 22.70, Uncertain significance, Inborn genetic diseases
- I21L (p.Ile21Leu), ExAC rs764171478, gnomAD rs764171478, REVEL 0.12, CADD 0.13
- I21T (p.Ile21Thr), ExAC rs758553006, gnomAD rs758553006, REVEL 0.03, CADD 13.20
- I21V (p.Ile21Val), ExAC rs764171478, gnomAD rs764171478, REVEL 0.11, CADD 0.00
- G23S (p.Gly23Ser), TOPMed rs1197437606
- G24R (p.Gly24Arg), ESP rs371503785, ExAC rs371503785, TOPMed rs371503785, gnomAD rs371503785, REVEL 0.45, CADD 15.20, Likely benign
- G24S (p.Gly24Ser), rs371503785, ClinGen CA6588847, ClinVar RCV003254898, ESP rs371503785, REVEL 0.37, CADD 14.50, Likely benign, Inborn genetic diseases
- K26N (p.Lys26Asn), Ensembl rs1939962572
- K26T (p.Lys26Thr), Ensembl rs1939963161
- R27K (p.Arg27Lys), Ensembl rs1939962524
- G28D (p.Gly28Asp), TOPMed rs1380634680, gnomAD rs1380634680, REVEL 0.18, CADD 0.59
- G28V (p.Gly28Val), NCI-TCGA Cosmic COSV5340, REVEL 0.17, CADD 0.31, Variant assessed as somatic; moderate impact.
- A29V (p.Ala29Val), rs2498789692, ClinGen CA384991291, ClinVar RCV004414389, REVEL 0.27, CADD 16.80, Uncertain significance, Inborn genetic diseases
- S31C (p.Ser31Cys), ExAC rs761074216, gnomAD rs761074216, REVEL 0.63, CADD 24.10, Uncertain significance, Inborn genetic diseases
- S31N (p.Ser31Asn), TOPMed rs1401851804, gnomAD rs1401851804, REVEL 0.47, CADD 23.40, Uncertain significance, Inborn genetic diseases
- V33F (p.Val33Phe), ESP rs376868011, ExAC rs376868011, TOPMed rs376868011, gnomAD rs376868011, REVEL 0.06, CADD 1.37
- V33I (p.Val33Ile), ESP rs376868011, ExAC rs376868011, TOPMed rs376868011, gnomAD rs376868011, REVEL 0.07, CADD 0.58
- S34F (p.Ser34Phe), TOPMed rs1433136873, gnomAD rs1433136873, REVEL 0.52, CADD 24.20
- S34P (p.Ser34Pro), TOPMed rs1939962030, Uncertain significance, Inborn genetic diseases
- M35T (p.Met35Thr), ExAC rs748899502, gnomAD rs748899502, REVEL 0.15, CADD 13.30
- S36F (p.Ser36Phe), TOPMed rs1176595490, gnomAD rs1176595490, REVEL 0.30, CADD 23.00, Uncertain significance, Inborn genetic diseases
- G37* (p.Gly37Ter), NCI-TCGA Cosmic COSV9954, Variant assessed as somatic; high impact.
- G37A (p.Gly37Ala), NCI-TCGA Cosmic COSV5340, Variant assessed as somatic; moderate impact.
- G37E (p.Gly37Glu), gnomAD rs1469775979, REVEL 0.43, CADD 22.60
- G38S (p.Gly38Ser), gnomAD rs1427716418, REVEL 0.47, CADD 19.90
- A39D (p.Ala39Asp), gnomAD rs1195793164, REVEL 0.35, CADD 16.40
- A39S (p.Ala39Ser), ExAC rs769231045, TOPMed rs769231045, gnomAD rs769231045, REVEL 0.07, CADD 6.09
- A39T (p.Ala39Thr), ExAC rs769231045, TOPMed rs769231045, gnomAD rs769231045, REVEL 0.20, CADD 10.40
- A39V (p.Ala39Val), gnomAD rs1195793164, REVEL 0.14, CADD 12.10
- G40D (p.Gly40Asp), ExAC rs745806170, TOPMed rs745806170, gnomAD rs745806170, REVEL 0.37, CADD 22.80, Uncertain significance, Inborn genetic diseases
- R41* (p.Arg41Ter), ExAC rs781063765, TOPMed rs781063765, gnomAD rs781063765, CADD 35.00
- R41Q (p.Arg41Gln), rs36143766, ClinGen CA6588836, ClinVar RCV000329958, ClinVar RCV003920287, REVEL 0.28, CADD 16.40, Benign, not provided; White sponge nevus 1
- C42* (p.Cys42Ter), TOPMed rs1939961410, gnomAD rs1939961410, CADD 36.00
- C42F (p.Cys42Phe), NCI-TCGA Cosmic COSV5340, Variant assessed as somatic; moderate impact.
- C42S (p.Cys42Ser), rs2498789611, ClinGen CA384991220, ClinVar RCV002737062, Uncertain significance, Inborn genetic diseases
- S43F (p.Ser43Phe), TOPMed rs1463406402, gnomAD rs1463406402, REVEL 0.30, CADD 23.20
- S43Y (p.Ser43Tyr), TOPMed rs1463406402, gnomAD rs1463406402, REVEL 0.30, CADD 22.70
- S44P (p.Ser44Pro), TOPMed rs1486488577, gnomAD rs1486488577, REVEL 0.11, CADD 21.40
- G45R (p.Gly45Arg), gnomAD rs1234351209, REVEL 0.49, CADD 23.70, Uncertain significance
- G45W (p.Gly45Trp), rs1234351209, ClinGen CA384991199, ClinVar RCV002984684, gnomAD rs1234351209, REVEL 0.57, CADD 24.50, Uncertain significance, Inborn genetic diseases
- G46E (p.Gly46Glu), rs1221027800, NCI-TCGA Cosmic COSV5340, gnomAD rs1221027800, REVEL 0.58, CADD 24.20, Variant assessed as somatic; moderate impact.
- G46R (p.Gly46Arg), rs1294012289, NCI-TCGA Cosmic COSV5341, gnomAD rs1294012289, REVEL 0.59, CADD 24.80, Variant assessed as somatic; moderate impact.
- G46V (p.Gly46Val), gnomAD rs1221027800, REVEL 0.61, CADD 24.10
- G48D (p.Gly48Asp), NCI-TCGA Cosmic COSV9954, Variant assessed as somatic; moderate impact.
- S49N (p.Ser49Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S49R (p.Ser49Arg), gnomAD rs1341177953
- R50K (p.Arg50Lys), gnomAD rs1312422280
- S51N (p.Ser51Asn), Ensembl rs1939960862, REVEL 0.54, CADD 24.40
- S51R (p.Ser51Arg), ExAC rs752880188, gnomAD rs752880188, REVEL 0.79, CADD 22.30
- L52F (p.Leu52Phe), ESP rs370960727, ExAC rs370960727, gnomAD rs370960727, REVEL 0.55, CADD 25.10
- Y53H (p.Tyr53His), TOPMed rs1294957370, REVEL 0.22, CADD 17.00
- L55P (p.Leu55Pro), rs1217672254, ClinGen CA384991128, NCI-TCGA Cosmic COSV5340, ClinVar RCV002817940, REVEL 0.49, CADD 23.40, Uncertain significance, Inborn genetic diseases
- R56W (p.Arg56Trp), TOPMed rs937760611, gnomAD rs937760611, REVEL 0.05, CADD 19.10
- G57E (p.Gly57Glu), NCI-TCGA Cosmic COSV9954, TOPMed rs1939960296, Variant assessed as somatic; moderate impact.
- G57R (p.Gly57Arg), NCI-TCGA Cosmic COSV5340, NCI-TCGA Cosmic COSV9954, REVEL 0.36, CADD 16.60, Variant assessed as somatic; moderate impact.
- G57V (p.Gly57Val), TOPMed rs1939960296, REVEL 0.32, CADD 18.30
- G57W (p.Gly57Trp), NCI-TCGA Cosmic COSV5340, NCI-TCGA Cosmic COSV9954, Variant assessed as somatic; moderate impact.
- N58D (p.Asn58Asp), Ensembl rs1592312372
- N58I (p.Asn58Ile), TOPMed rs926500542
- N58K (p.Asn58Lys), TOPMed rs905272775, gnomAD rs905272775, REVEL 0.11, CADD 4.99
- N58S (p.Asn58Ser), TOPMed rs926500542, REVEL 0.03, CADD 2.62
- K59E (p.Lys59Glu), gnomAD rs982339709, REVEL 0.34, CADD 21.60
- K59R (p.Lys59Arg), TOPMed rs1254737250, gnomAD rs1254737250, REVEL 0.06, CADD 14.70
- S60G (p.Ser60Gly), ExAC rs755069625, gnomAD rs755069625, REVEL 0.17, CADD 19.50
- S60I (p.Ser60Ile), TOPMed rs1416524668, gnomAD rs1416524668, REVEL 0.44, CADD 17.10
- S60N (p.Ser60Asn), rs1416524668, NCI-TCGA Cosmic COSV5340, TOPMed rs1416524668, gnomAD rs1416524668, REVEL 0.28, CADD 15.10, Variant assessed as somatic; moderate impact.
- I61M (p.Ile61Met), TOPMed rs1939959751, REVEL 0.08, CADD 16.80
- I61T (p.Ile61Thr), TOPMed rs1939959799, REVEL 0.11, CADD 14.30
- S62F (p.Ser62Phe), TOPMed rs1939959701, gnomAD rs1939959701, REVEL 0.25, CADD 19.70
- M63T (p.Met63Thr), NCI-TCGA Cosmic COSV9954, Variant assessed as somatic; moderate impact.
- S64C (p.Ser64Cys), NCI-TCGA TCGA novel, REVEL 0.30, CADD 22.30, Variant assessed as somatic; moderate impact.
- V65M (p.Val65Met), rs754420448, ClinGen CA6588827, ClinVar RCV001110877, ClinVar RCV002558110, REVEL 0.12, CADD 3.93, Conflicting interpretations, White sponge nevus 1; Inborn genetic diseases
- A66T (p.Ala66Thr), NCI-TCGA Cosmic COSV5340, REVEL 0.19, CADD 23.40, Variant assessed as somatic; moderate impact.
- G67E (p.Gly67Glu), ExAC rs766973552, TOPMed rs766973552, gnomAD rs766973552, REVEL 0.33, CADD 19.40
- G67V (p.Gly67Val), ExAC rs766973552, TOPMed rs766973552, gnomAD rs766973552, REVEL 0.21, CADD 22.40
- S68A (p.Ser68Ala), ExAC rs763869321, TOPMed rs763869321, gnomAD rs763869321, REVEL 0.11, CADD 2.86
- S68P (p.Ser68Pro), ExAC rs763869321, TOPMed rs763869321, gnomAD rs763869321
- R69* (p.Arg69Ter), 1000Genomes rs200860840, ESP rs200860840, ExAC rs200860840, TOPMed rs200860840, CADD 36.00, Likely benign
- R69P (p.Arg69Pro), ExAC rs769322571, TOPMed rs769322571, gnomAD rs769322571, REVEL 0.19, CADD 20.90, Uncertain significance, Inborn genetic diseases
- R69Q (p.Arg69Gln), rs769322571, NCI-TCGA Cosmic COSV5340, ExAC rs769322571, TOPMed rs769322571, REVEL 0.05, CADD 15.70, Variant assessed as somatic; moderate impact.
- Q70E (p.Gln70Glu), Ensembl rs2121257963, REVEL 0.22, CADD 17.60
- Q70K (p.Gln70Lys), Ensembl rs2121257963, REVEL 0.26, CADD 18.50
- Q70P (p.Gln70Pro), TOPMed rs1293226865, gnomAD rs1293226865, REVEL 0.37, CADD 22.40
- G71A (p.Gly71Ala), ExAC rs776597302, gnomAD rs776597302, REVEL 0.26, CADD 22.60
- G71C (p.Gly71Cys), 1000Genomes rs201431252, ESP rs201431252, ExAC rs201431252, TOPMed rs201431252, REVEL 0.51, CADD 28.50, Uncertain significance
- G71D (p.Gly71Asp), NCI-TCGA Cosmic COSV5340, REVEL 0.48, CADD 23.80, Variant assessed as somatic; moderate impact.
- G71S (p.Gly71Ser), 1000Genomes rs201431252, ESP rs201431252, ExAC rs201431252, TOPMed rs201431252, REVEL 0.18, CADD 23.00, Uncertain significance, Inborn genetic diseases
- G71V (p.Gly71Val), ExAC rs776597302, gnomAD rs776597302, REVEL 0.47, CADD 27.60
- A72D (p.Ala72Asp), 1000Genomes rs2638525, ESP rs2638525, ExAC rs2638525, TOPMed rs2638525, REVEL 0.23, CADD 16.10, Benign, in allele K4A1
- A72P (p.Ala72Pro), ExAC rs770823399, TOPMed rs770823399, gnomAD rs770823399, REVEL 0.31, CADD 22.70
- A72V (p.Ala72Val), rs2638525, ClinGen CA6588815, ClinVar RCV000333357, ClinVar RCV001672476, REVEL 0.06, CADD 12.90, Benign, not provided; White sponge nevus 1
- C73G (p.Cys73Gly), ExAC rs777416638, REVEL 0.07, CADD 8.94
- C73Y (p.Cys73Tyr), NCI-TCGA TCGA novel, Ensembl rs1939958547, REVEL 0.22, CADD 16.30, Variant assessed as somatic; moderate impact.
- G75A (p.Gly75Ala), 1000Genomes rs200665579, ESP rs200665579, ExAC rs200665579, TOPMed rs200665579, REVEL 0.65, CADD 22.00, Benign
- G75E (p.Gly75Glu), rs200665579, ClinGen CA6588812, ClinVar RCV000268826, 1000Genomes rs200665579, REVEL 0.70, CADD 23.70, Benign, White sponge nevus 1
- G75R (p.Gly75Arg), TOPMed rs111875720, REVEL 0.67, CADD 22.90
- G75W (p.Gly75Trp), TOPMed rs111875720, REVEL 0.61, CADD 23.90
- G76A (p.Gly76Ala), ExAC rs753941027, gnomAD rs753941027, REVEL 0.02, CADD 8.01
- G76S (p.Gly76Ser), TOPMed rs1939958269
- G76V (p.Gly76Val), ExAC rs753941027, gnomAD rs753941027, REVEL 0.09, CADD 11.20
- A77T (p.Ala77Thr), ExAC rs756562144, REVEL 0.33, CADD 16.80
- G78A (p.Gly78Ala), Ensembl rs2121257837, REVEL 0.10, CADD 12.10
- G78E (p.Gly78Glu), NCI-TCGA Cosmic COSV5340, Variant assessed as somatic; moderate impact.
- G78R (p.Gly78Arg), gnomAD rs1939957981, REVEL 0.34, CADD 22.30
- G79S (p.Gly79Ser), TOPMed rs1939957853
- F80S (p.Phe80Ser), TOPMed rs1358486451
- F80Y (p.Phe80Tyr), TOPMed rs1358486451
- G83S (p.Gly83Ser), Ensembl rs1435291527
- F85S (p.Phe85Ser), Ensembl rs1939957015
- G87A (p.Gly87Ala), Ensembl rs76773498
- G87R (p.Gly87Arg), TOPMed rs1358397271
- G88V (p.Gly88Val), NCI-TCGA Cosmic COSV9954, Variant assessed as somatic; moderate impact.
- F89S (p.Phe89Ser), ESP rs370214897, ExAC rs370214897, TOPMed rs370214897, gnomAD rs370214897, REVEL 0.24, CADD 18.90
- G90V (p.Gly90Val), Ensembl rs1939955492, REVEL 0.60, CADD 23.40
- G90W (p.Gly90Trp), ExAC rs760542950, TOPMed rs760542950, gnomAD rs760542950, REVEL 0.49, CADD 25.80
- G91V (p.Gly91Val), ExAC rs773161343, gnomAD rs773161343, REVEL 0.48, CADD 23.40
- S92F (p.Ser92Phe), gnomAD rs1452535421, REVEL 0.15, CADD 13.10
- S92P (p.Ser92Pro), Ensembl rs2121257615, REVEL 0.24, CADD 16.70
- F93Y (p.Phe93Tyr), Ensembl rs2121257604
- S94N (p.Ser94Asn), Ensembl rs2121257597
- G95D (p.Gly95Asp), NCI-TCGA Cosmic COSV5340, Variant assessed as somatic; moderate impact.
- K96* (p.Lys96Ter), NCI-TCGA Cosmic COSV9954, Variant assessed as somatic; high impact.
- K96T (p.Lys96Thr), ExAC rs747951356, gnomAD rs747951356, REVEL 0.04, CADD 6.50
- G97S (p.Gly97Ser), NCI-TCGA Cosmic COSV9954, REVEL 0.46, CADD 22.00, Variant assessed as somatic; moderate impact.
- G98S (p.Gly98Ser), ExAC rs749433758, gnomAD rs749433758, REVEL 0.32, CADD 21.60
- P99L (p.Pro99Leu), TOPMed rs1939954801, REVEL 0.22, CADD 16.20
- G100D (p.Gly100Asp), ExAC rs780291229, gnomAD rs780291229, REVEL 0.72, CADD 23.40
- F101I (p.Phe101Ile), Ensembl rs2121257545
- F101L (p.Phe101Leu), TOPMed rs1009740435, gnomAD rs1009740435, REVEL 0.39, CADD 15.40
- P102S (p.Pro102Ser), Ensembl rs866953537
- V103A (p.Val103Ala), TOPMed rs1454609245, gnomAD rs1454609245, REVEL 0.28, CADD 7.43
- V103I (p.Val103Ile), rs371081693, ClinGen CA6588780, ClinVar RCV002682727, ESP rs371081693, REVEL 0.35, CADD 14.80, Uncertain significance, Inborn genetic diseases
- C104F (p.Cys104Phe), ExAC rs757613926, TOPMed rs757613926, gnomAD rs757613926, REVEL 0.42, CADD 23.70
- C104G (p.Cys104Gly), gnomAD rs1381704972, REVEL 0.35, CADD 23.90
- C104R (p.Cys104Arg), gnomAD rs1381704972, REVEL 0.55, CADD 24.10
- P105S (p.Pro105Ser), gnomAD rs1440646814, REVEL 0.41, CADD 23.80
- A106G (p.Ala106Gly), rs753431318, ClinGen CA6588775, ClinVar RCV001110120, ClinVar RCV004032150, REVEL 0.30, CADD 22.90, Uncertain significance, Inborn genetic diseases; White sponge nevus 1
- A106P (p.Ala106Pro), ESP rs199642796, ExAC rs199642796, TOPMed rs199642796, gnomAD rs199642796, REVEL 0.22, CADD 4.02, Uncertain significance
- A106S (p.Ala106Ser), ESP rs199642796, ExAC rs199642796, TOPMed rs199642796, gnomAD rs199642796, REVEL 0.14, CADD 9.47, Uncertain significance
- A106T (p.Ala106Thr), rs199642796, ESP rs199642796, ExAC rs199642796, TOPMed rs199642796, REVEL 0.18, CADD 14.30, Uncertain significance, Inborn genetic diseases
- G107E (p.Gly107Glu), rs904956619, NCI-TCGA Cosmic COSV9954, TOPMed rs904956619, gnomAD rs904956619, REVEL 0.71, AlphaMissense 0.28, Variant assessed as somatic; moderate impact.
- G107R (p.Gly107Arg), NCI-TCGA Cosmic COSV9954, REVEL 0.58, CADD 26.40, Variant assessed as somatic; moderate impact.
- G107V (p.Gly107Val), rs904956619, ClinGen CA384990818, ClinVar RCV004412398, AlphaMissense 0.28, MetaLR 0.97, Uncertain significance, Inborn genetic diseases
- G108E (p.Gly108Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- I109V (p.Ile109Val), gnomAD rs1939953668, REVEL 0.53, CADD 24.70
- Q110R (p.Gln110Arg), 1000Genomes rs533929594, ExAC rs533929594, gnomAD rs533929594, REVEL 0.36, CADD 22.90
- E111D (p.Glu111Asp), ExAC rs773070973, TOPMed rs773070973, gnomAD rs773070973, REVEL 0.43, CADD 21.10
- E111G (p.Glu111Gly), 1000Genomes rs202175412, ExAC rs202175412, REVEL 0.33, CADD 23.80, Uncertain significance, Inborn genetic diseases
- E111K (p.Glu111Lys), Ensembl rs1939953544, REVEL 0.41, CADD 22.70
- V112A (p.Val112Ala), TOPMed rs1939953334, REVEL 0.83, CADD 25.40
- V112F (p.Val112Phe), TOPMed rs1292366339, gnomAD rs1292366339, REVEL 0.76, CADD 24.60
- T113I (p.Thr113Ile), ExAC rs767456647, gnomAD rs767456647, REVEL 0.41, CADD 21.60, Uncertain significance, Inborn genetic diseases
Public KRT4 analysis runs
- KRT4 analysis run — KRT4 (968 variants) — completed 2026-08-22